Aug 26, 2025
1:4
For every 4 shares held, investors received 1. The price per share adjusted from $0.85 to $0.21.
The split itself did not change the total investment value.
Chemomab Therapeutics Ltd. (CMMB) trades on the NASDAQ Capital Market in the Biotechnology industry.
Chemomab Therapeutics Ltd. company overviewThe latest split shown was on August 26, 2025. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
This history records 2 reverse splits between March 17, 2021 and August 26, 2025.
Already premium? Sign in